Enterprise
Pricing
Explore API
Get a demo
Get started
Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Immunovant

May 2026

Immunovant Market Share Analysis for May 2026

. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn). Website https://www.immunovant.com.
Health > Biotechnology and Pharmaceuticals
Domainimmunovant.com
Year Founded2018
Employees201 - 500
Annual Revenue$5M - $10M
HQ:United States, New York, New York City
immunovant.com
Immunovant
Immunovant (including company regionals)
  • immunovant.com
    immunovant.com
See more website traffic and engagement information

Immunovant Revenue up to May 2026 is 5M - 10M

revenue generated by Immunovant top domains

Immunovant top domains revenue over 3 years

Revenue for Immunovant top domains

immunovant.comimmunovant.com5M - 10M
See more with Sales Intelligence

Total visits to Immunovant's top domains

Understand Immunovant market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
immunovant.comimmunovant.com10.3K
See more with Sales Intelligence

Avg. visit duration in Immunovant's top domains

Analyze Immunovant engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
immunovant.comimmunovant.com00:00:40
See more with Sales Intelligence

Avg. pageviews on Immunovant's top domains

See how Immunovant keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
immunovant.comimmunovant.com1.69
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.

Immunovant top competitors by domain

Top similar sites in May 2026, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.

Top technologies used by Immunovant

These are the website technologies, by industry, used by Immunovant top domains

Payment & Currencies (7)

Cart Functionality

Cart Functionality

See all

Widget (5)

Twemoji

Twemoji

See all

Advertising (2)

DoubleClick

DoubleClick

See all

Content Management System (2)

WordPress

WordPress

See all

More Technologies

10

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.

News & Signals from Immunovant

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImmunovant, Inc. is developing IMVT-1402.Another catalyst is that the company owns a majority stake in Immunovant, which is developing IMVT-1402, a potential best-in-class treatment for autoimmune diseases.
April 27, 2026Read More
NewsImmunovant, Inc. is planning to receive financing of $550M in common stock financing.Immunovant announces pricing of $550 million common stock financing.
December 11, 2025Read More
NewsImmunovant, Inc. has issues with discriminatory hiring.Immunovant Inc. is accused of discriminatory hiring due to the use of artificial intelligence in the hiring process.
April 7, 2025Read More

See all Immunovant signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.